Form 8-K - Current report:
SEC Accession No. 0001193125-24-147013
Filing Date
2024-05-24
Accepted
2024-05-24 16:02:04
Documents
13
Period of Report
2024-05-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d95239d8k.htm   iXBRL 8-K 38957
  Complete submission text file 0001193125-24-147013.txt   158381

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20240521.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20240521_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20240521_pre.xml EX-101.PRE 10815
17 EXTRACTED XBRL INSTANCE DOCUMENT d95239d8k_htm.xml XML 3532
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 24984143
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)